PAIN TRIGGERS
Relapsing back to cigarettes after periods of quitting despite ADHD medication.
Fear of weight gain from binge eating when trying to quit smoking.
SaaS· Young adults with ADHD and autismPain 7.00/10WTP 6.0/10Market 7.0/10Validation 8.0Confidence 72%May 17, 2026
DopamineGuard: ADHD Smoking Quit App with Binge & Weight Control
ADHD/autism patients on Ritalin still relapse to cigarettes for dopamine boosts and appetite control, with binge eating and weight gain fears blocking permanent quitting; standard methods fail this dual neurochemical need.
addictionadhdai-poweredhealthcaremental-healthmobile-appneurodivergentproductivitysaaswellness
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD and autism patients on stimulants like Ritalin still relapse into cigarette smoking for dopamine and appetite suppression, fearing weight gain from binge eating.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
How do I stop smoking? [BUT SERIOUSLY]
ADHD614
How do I stop smoking? [BUT SERIOUSLY]
ADHD614
it just as much about an eating disorder as it is a nicotine addiction
commentMaybe see a therapist if its about weight gain. I sounds like it just as much about an eating disorder as it is a nicotine addiction so any normal quitting method won't work
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
Young adults with ADHD and autismA D H D Stimulant Users Who Smoke
Neurodivergent young adults prescribed Ritalin or similar who rely on cigarettes for extra dopamine and appetite suppression but cycle through failed quit attempts due to binge eating fears and weight gain.
Context
Quit smoking cigarettes permanently while preventing weight gain and managing binge eating urges.
Using cigarettes specifically for appetite suppression to avoid bingeing.
Cycling between quitting and restarting smoking.
Current Workarounds
Cycling between quitting and restarting cigarettes
Using Zyns, vaping, or gum as partial nicotine substitutes
Smoking specifically to suppress binge urges
Avoiding standard quit programs that ignore ADHD + eating issues
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Ritalin does not eliminate need for nicotine dopamine boost.
Standard quitting methods fail to address combined ADHD, binge eating, and appetite concerns.
Cold turkey or simple switches do not work reliably for this group.
OPPORTUNITY & VALUE
Why Now
Multiple strong signals on relapse despite meds and weight gain fear as dominant barrier; explicit calls for replacement solutions.
Value Proposition
Solely focused on the ADHD + nicotine + binge eating intersection ignored by generic quit or weight apps.
Product Direction
Mobile app delivering personalized daily plans combining ADHD-friendly dopamine alternatives (non-nicotine), real-time binge urge tools, meal templates to prevent weight gain, and progress tracking synced to medication routines.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$19/moCore app + daily plans
Model
SaaS subscription
WILLINGNESS TO PAY
Users already pay for Ritalin prescriptions and repeatedly attempt quitting; they express strong fear of weight gain as primary barrier, indicating willingness to pay for a tool that directly solves the combined dopamine/appetite gap where free methods fail.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Quit cigarettes for good while staying slim and focused on ADHD meds.”
Mobile app delivering personalized daily plans combining ADHD-friendly dopamine alternatives (non-nicotine), real-time binge urge tools, meal templates to prevent weight gain, and progress tracking synced to medication routines.
Core Features
Daily dopamine menu with quick non-nicotine activities
Binge urge interrupter with 5-min timed tools and logging
Simple meal planner with appetite-stabilizing recipes
Medication + smoking streak tracker with relapse prediction
Weekly Roadmap
1
W1-W2
Core tracking and daily dopamine menu functional for single user.
- •Build user onboarding with ADHD/meds profile
- •Implement streak and urge logging database
- •Create simple dopamine activity menu
2
W3-W4
Binge tools and meal planner integrated and testable.
- •Develop 5-min urge interrupter timer + prompts
- •Add basic recipe/meal template library
- •Link medication reminder to craving predictions
3
W5
Polish, internal testing with 10 beta users from Reddit.
- •UI/UX refinements for focus-friendly design
- •Recruit and onboard 10 ADHD users for feedback
- •Basic analytics dashboard for streaks
4
W6
Public beta launch with first subscribers.
- •Stripe integration for subscriptions
- •Post on r/ADHD and r/leaves with beta link
- •Collect first-week retention metrics
Launch Strategy
Reddit communities (r/ADHD, r/leaves, r/autism), targeted TikTok/Instagram ads to young neurodivergent adults, partnerships with ADHD coaches.
RISKS & ASSUMPTIONS
Top Risks
Regulatory and medical risk
Health claims around addiction, ADHD, and eating disorders may require disclaimers or clinical backing to avoid legal issues.
User retention on dopamine substitutes
Non-nicotine alternatives may not satisfy intense cravings, leading to high early dropout.
Competition from free nicotine alternatives
Users already default to cheap Zyns/vapes; convincing switch to paid app is challenging.
Data privacy for health tracking
Sensitive ADHD/medication/smoking data requires strong compliance.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "addiction", "adhd", "ai-powered", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "DopamineGuard: ADHD Smoking Quit App with Binge & Weight Control" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for addiction?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.